Baird Financial Group
TNDM icon

Baird Financial Group’s Tandem Diabetes Care TNDM Stock Holding History

Baird Financial Group’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,169
Closed -$225K – 1759
2023
Q2 		$225K Buy
9,169
+990
+12% +$31.9K ﹤0.01% 1581
2023
Q1 		$332K Sell
8,179
-354
-4% -$14.7K ﹤0.01% 1455
2022
Q4 		$384K Sell
8,533
-11,798
-58% -$534K ﹤0.01% 1388
2022
Q3 		$973K Sell
20,331
-8,178
-29% -$448K ﹤0.01% 1060
2022
Q2 		$1.69M Buy
28,509
+3,119
+12% +$256K ﹤0.01% 910
2022
Q1 		$2.95M Buy
25,390
+16,771
+195% +$1.96M 0.01% 762
2021
Q4 		$1.3M Sell
8,619
-433
-5% -$58.4K ﹤0.01% 1100
2021
Q3 		$1.08M Buy
+9,052
New +$997K ﹤0.01% 1178
2020
Q4 		– Sell
-6,294
Closed -$714K – 1599
2020
Q3 		$714K Sell
6,294
-6,407
-50% -$673K ﹤0.01% 1049
2020
Q2 		$1.26M Buy
12,701
+8,907
+235% +$711K ﹤0.01% 869
2020
Q1 		$244K Buy
+3,794
New +$266K ﹤0.01% 1269

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Baird Financial Group's TNDM Position: Q3 2023 in Review

Baird Financial Group sold out of Tandem Diabetes Care (TNDM) in Q3 2023, closing a stake of 9,169 shares — an estimated $225K sold.

Baird Financial Group first reported a position in TNDM in Q1 2020 and held it in 11 quarters. The position peaked at $2.95M in Q1 2022. 226 funds tracked by Wall St. Rank hold TNDM as of Q3 2023.

  • Baird Financial Group reported no remaining Tandem Diabetes Care position as of Q3 2023 after selling out during the quarter.
  • Baird Financial Group sold 9,169 Tandem Diabetes Care shares in Q3 2023, an estimated $225K.
  • Baird Financial Group first reported a position in Tandem Diabetes Care in Q1 2020 and held it in 11 quarters.
  • Baird Financial Group's Tandem Diabetes Care position peaked at $2.95M in Q1 2022.
  • 226 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2023.

Based on Baird Financial Group's 13F filing for Q3 2023, filed 13 Nov 2023.